Economic Evaluation of Pediatric Cancer Treatment: A Systematic Literature Review
- 1 January 2013
- journal article
- review article
- Published by American Academy of Pediatrics (AAP)
- Vol. 131 (1), e273-e287
- https://doi.org/10.1542/peds.2012-0912
Abstract
OBJECTIVE: Although there is a growing national focus on health care cost containment and accountability in resource utilization, childhood cancer therapy costs continue to increase without proportionate survival improvements. Economic evaluations (EEs) such as cost and/or cost effectiveness analysis may identify areas to improve resource efficiency. This review aims to identify and characterize the EE studies performed in this field. METHODS: We performed a structured literature search of the Medline, PubMed, and the National Health Service EE databases from 2000 to 2011. Concepts for the search included “cost analyses,” “child,” and “cancer.” Studies were limited to original research, comparison of 2 or more treatments using monetary units, English language, and originating from economically developed countries. Identified studies were assessed by the Drummond checklist and characterized by the therapy studied, data sources, and research perspectives. RESULTS: Forty studies met inclusion criteria. Eleven studied chemotherapy, surgery, or radiation. Twenty-nine studied supportive measures such as growth factor support or treatment of infection. The median Drummond score was 6 of 10 (range, 2–9). Only 15 (36%) included treatment outcomes when comparing costs. Methodological limitations were common. CONCLUSIONS: A wide variety of topics and methodological limitations made comparisons between studies difficult. Strategies for increasing the generalizability of future EE studies are presented. Substantial opportunity exists for EE research in childhood cancer.Keywords
This publication has 51 references indexed in Scilit:
- Physical, Mental, and Neurocognitive Status and Employment Outcomes in the Childhood Cancer Survivor Study CohortCancer Epidemiology, Biomarkers & Prevention, 2011
- Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and applicationClinicoEconomics and Outcomes Research, 2011
- Sensitivity Analysis in Cost-Effectiveness StudiesPharmacoEconomics, 2011
- The Costs and Cost-Effectiveness of Allogeneic Peripheral Blood Stem Cell Transplantation versus Bone Marrow Transplantation in Pediatric Patients with Acute LeukemiaTransplantation and Cellular Therapy, 2010
- Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First CenturyJournal of Clinical Oncology, 2010
- A review of health utilities across conditions common in paediatric and adult populationsHealth and Quality of Life Outcomes, 2010
- CEFEPIME VERSUS CETAZIDIME+AMIKACIN AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIA IN CHILDREN WITH CANCER: A Prospective Randomized Trial of the Treatment Efficacy and CostPediatric Hematology and Oncology, 2005
- Economic evaluation of treatments for cancer in childhoodEuropean Journal Of Cancer, 2004
- Individual timing of blood counts in G-CSF prophylaxis after myelosuppressive chemotherapy reduces G-CSF injections, blood counts, and costs: a prospective randomized study in children and adolescentsSupportive Care in Cancer, 2002
- Use of Randomised Controlled Trials for Producing Cost-Effectiveness EvidencePharmacoEconomics, 2002